Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanchen Zhang

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Clinical Child and Family Psychology Review|June 17, 2024
Brief School-Based Interventions Targeting Student Mental Health or Well-Being: A Systematic Review and Meta-AnalysisKatherine A Cohen, Sakura Ito, Isaac L Ahuvia, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 7, 2025
TSHR-Targeting Nucleic Acid Aptamer Treats Graves' Ophthalmopathy via Novel Allosteric InhibitionYanchen Zhang, Ende Wu, Weibin Liu, et al.
Science Advances|January 1, 2026
Engineered anchoring aptamers induce relocalization and functional inactivation of transcription factorsNeng Ling, Hui Wu, Yibin Zhang, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Synthesis and in Vitro and in Vivo Evaluation of Phosphoinositide-3-kinase InhibitorsMatthew T Burger, Mark Knapp, Allan Wagman, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Structure Guided Optimization, in Vitro Activity, and in Vivo Activity of Pan-PIM Kinase InhibitorsMatthew T Burger, Wooseok Han, Jiong Lan, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating CancerMatthew T Burger, Sabina Pecchi, Allan Wagman, et al.
Journal of Medicinal Chemistry|October 28, 2015
Identification of N-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological MalignanciesMatthew T Burger, Gisele Nishiguchi, Wooseok Han, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2013
Discovery of a novel class of boron-based antibacterials with activity against gram-negative bacteriaVincent Hernandez, Thibaut Crépin, Andrés Palencia, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Clinical Child and Family Psychology Review|June 17, 2024
Brief School-Based Interventions Targeting Student Mental Health or Well-Being: A Systematic Review and Meta-AnalysisKatherine A Cohen, Sakura Ito, Isaac L Ahuvia, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 7, 2025
TSHR-Targeting Nucleic Acid Aptamer Treats Graves' Ophthalmopathy via Novel Allosteric InhibitionYanchen Zhang, Ende Wu, Weibin Liu, et al.
Science Advances|January 1, 2026
Engineered anchoring aptamers induce relocalization and functional inactivation of transcription factorsNeng Ling, Hui Wu, Yibin Zhang, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Synthesis and in Vitro and in Vivo Evaluation of Phosphoinositide-3-kinase InhibitorsMatthew T Burger, Mark Knapp, Allan Wagman, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Structure Guided Optimization, in Vitro Activity, and in Vivo Activity of Pan-PIM Kinase InhibitorsMatthew T Burger, Wooseok Han, Jiong Lan, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating CancerMatthew T Burger, Sabina Pecchi, Allan Wagman, et al.
Journal of Medicinal Chemistry|October 28, 2015
Identification of N-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological MalignanciesMatthew T Burger, Gisele Nishiguchi, Wooseok Han, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2013
Discovery of a novel class of boron-based antibacterials with activity against gram-negative bacteriaVincent Hernandez, Thibaut Crépin, Andrés Palencia, et al.
Pageof 5